首页> 外文期刊>Protoplasma: An International Journal of Cell Biology >Does 2,3-butanedione monoxime inhibit nonmuscle myosin?
【24h】

Does 2,3-butanedione monoxime inhibit nonmuscle myosin?

机译:2,3-丁二酮单肟抑制非肌肉肌球蛋白吗?

获取原文
获取原文并翻译 | 示例
           

摘要

BDM (2,3-butanedione monoxime) has been used extensively to inhibit nonmuscle myosin. However, recent articles raise the question of what BDM actually does, because of experiments in which BDM did not affect the actin-activated ATPase of nonmuscle myosins. We describe results that indicate that BDM indeed inhibits motility due to nonmuscle myosins: in many different cells BDM has the same effects as anti-actin agents and/or as other anti-myosin agents, and BDM slows or stops the sliding between actin filaments and myosin in vitro. We discuss how the two sets of apparently contradictory results might be resolved, and we suggest possible experiments that might clarify the contradictory interpretations.
机译:BDM(2,3-丁二酮一肟)已被广泛用于抑制非肌肉肌球蛋白。但是,最近的文章提出了BDM实际作用的问题,因为实验中BDM不会影响肌非球蛋白的肌动蛋白激活的ATPase。我们描述的结果表明,BDM确实由于非肌肉肌球蛋白而抑制了运动:在许多不同的细胞中,BDM与抗肌动蛋白药物和/或其他抗肌球蛋白药物具有相同的作用,而BDM可以减缓或阻止肌动蛋白丝与肌动蛋白丝之间的滑动。体外肌球蛋白。我们讨论了如何解决两组明显矛盾的结果,并提出了可能阐明矛盾解释的可能的实验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号